Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burden.
作者信息
Daly Timothy, Imbimbo Bruno P
机构信息
UMR 1219 Bordeaux Population Health, Université de Bordeaux & INSERM, Bordeaux, France.
UMR 5164, ImmunoConcept, University of Bordeaux & CNRS, Bordeaux, France.
出版信息
Alzheimers Dement. 2025 Sep;21(9):e70614. doi: 10.1002/alz.70614.
Abstract
摘要
相似文献
1
Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burden.提高抗糖尿病药物的摄取以降低心脏代谢风险和痴呆负担。
Alzheimers Dement. 2025 Sep;21(9):e70614. doi: 10.1002/alz.70614.
2
Karway et al. respond to "Enhancing uptake of antidiabetic drugs to reduce cardiometabolic risk and dementia burden".卡尔韦等人回应《提高抗糖尿病药物的摄入量以降低心脏代谢风险和痴呆症负担》。
Alzheimers Dement. 2025 Sep;21(9):e70615. doi: 10.1002/alz.70615.
3
Neurodegeneration and Stroke After Semaglutide and Tirzepatide in Patients With Diabetes and Obesity.司美格鲁肽和替尔泊肽治疗糖尿病和肥胖症患者后的神经退行性变和中风
JAMA Netw Open. 2025 Jul 1;8(7):e2521016. doi: 10.1001/jamanetworkopen.2025.21016.
4
Cardiometabolic Multimorbidity and Dementia Onset Among Middle-Aged and Older Adults: Differences by Race/Ethnicity.中老年人心血管代谢多重疾病与痴呆症发病：按种族/族裔划分的差异
J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5). doi: 10.1093/gerona/glaf009.
5
Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset.老年人心脏代谢多病症的纵向测序及其与后续痴呆症发病的关联。
PLoS One. 2025 Jul 10;20(7):e0326309. doi: 10.1371/journal.pone.0326309. eCollection 2025.
6
Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis.2型糖尿病抗糖尿病药物认知结局的比较：一项系统评价和网状Meta分析。
Diabetes Metab Res Rev. 2023 Oct;39(7):e3673. doi: 10.1002/dmrr.3673. Epub 2023 Jun 11.
7
Dual energy X-ray absorptiometry-measured fat mass and lean mass indices and cardiometabolic diseases in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study.双能X线吸收法测量的老年日本男性脂肪量和瘦体重指数与心血管代谢疾病：藤原京男性骨质疏松症风险（FORMEN）研究
Environ Health Prev Med. 2025;30:59. doi: 10.1265/ehpm.25-00133.
8
Cardiometabolic Trajectories Preceding Dementia in Community-Dwelling Older Individuals.社区居住老年人痴呆症发生前的心脏代谢轨迹
JAMA Netw Open. 2025 Feb 3;8(2):e2458591. doi: 10.1001/jamanetworkopen.2024.58591.
9
Trajectory of Cardiometabolic Disease-Related Hospitalizations Before and After Dementia Diagnosis: A Matched Cohort Study.
J Am Med Dir Assoc. 2025 Jul;26(7):105594. doi: 10.1016/j.jamda.2025.105594. Epub 2025 May 9.
10
Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach.传统抗痴呆药物对经济负担的因果效应：一种正交双/去偏机器学习方法。
BMC Geriatr. 2025 Aug 25;25(1):659. doi: 10.1186/s12877-025-06298-6.
引用本文的文献
1
The cardiometabolic "bottleneck" on cognitive function in aging.衰老过程中心血管代谢对认知功能的“瓶颈”效应
Alzheimers Dement. 2025 Sep;21(9):e70685. doi: 10.1002/alz.70685.
本文引用的文献
1
ARTS is associated with vascular risk factors, MCI, dementia, and stroke.动脉粥样硬化性血栓性脑梗死与血管危险因素、轻度认知障碍、痴呆和中风相关。
Alzheimers Dement. 2025 Jul;21(7):e70430. doi: 10.1002/alz.70430.
2
Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia.可改变的中年及老年血管危险因素对新发痴呆症的影响
JAMA Neurol. 2025 Jun 2. doi: 10.1001/jamaneurol.2025.1495.
3
Regional variability of the impact of cardiometabolic diseases on incident dementia in United States Medicare beneficiaries.美国医疗保险受益人心血管代谢疾病对新发痴呆症影响的区域差异。
Alzheimers Dement. 2025 May;21(5):e70199. doi: 10.1002/alz.70199.
4
Beyond diabetes: Testing long-term metformin adherence for dementia prevention.
Diabetes Obes Metab. 2025 Aug;27(8):4615-4616. doi: 10.1111/dom.16472. Epub 2025 May 23.
5
Association Between Metabolic Syndrome and Young-Onset Dementia: A Nationwide Population-Based Study.代谢综合征与早发性痴呆之间的关联：一项基于全国人口的研究。
Neurology. 2025 May 27;104(10):e213599. doi: 10.1212/WNL.0000000000213599. Epub 2025 Apr 23.
6
Abdominal obesity and the risk of young-onset dementia in women: a nationwide cohort study.腹部肥胖与女性早发性痴呆风险：一项全国性队列研究。
Alzheimers Res Ther. 2025 Apr 21;17(1):86. doi: 10.1186/s13195-025-01738-2.
7
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.EVOKE和EVOKE+：两项大型、双盲、安慰剂对照的3期研究设计，评估司美格鲁肽在早期有症状阿尔茨海默病中的疗效、安全性和耐受性。
Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7.
8
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US.司美格鲁肽与2型糖尿病患者首次诊断阿尔茨海默病的关联：利用美国全国性真实世界数据进行目标试验模拟
Alzheimers Dement. 2024 Dec;20(12):8661-8672. doi: 10.1002/alz.14313. Epub 2024 Oct 24.
9
Associations of metabolic syndrome with cognitive function and dementia risk: Evidence from the UK Biobank cohort.代谢综合征与认知功能和痴呆风险的关联：来自英国生物库队列的证据。
Diabetes Obes Metab. 2024 Dec;26(12):6023-6033. doi: 10.1111/dom.15977. Epub 2024 Oct 3.
10
Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020.2015年至2020年3月心血管疾病患者和非心血管疾病患者使用心脏保护型抗糖尿病药物的情况
Ann Pharmacother. 2024 Mar;58(3):248-254. doi: 10.1177/10600280231178886. Epub 2023 Jun 15.
Zotero 插件